Follow the people · Insider
Mary C. Beckerle
Mary C. Beckerle files insider transactions with the SEC as a director of Exelixis (EXEL). We hold 2 disclosed purchases and sales filed since 9 May 2011, 1 of them in the last 90 days.
- Files forEXEL
- Disclosed buys and sells2 in all, 1 in the last 90 days
- Last disclosure12 August 2026
Positions held
3 posts we hold — a term names its own dates; a run of filings only says when they filed- Filed 5 January 2024 — 10 August 2026Director · Exelixis (EXEL)17 Form 4 lines · source: SEC Form 4
- Filed 8 February 2016 — 23 April 2026Director · Johnson & Johnson (JNJ)11 Form 4 lines · source: SEC Form 4
- Filed 5 May 2011 — 12 February 2026Director · Huntsman (HUN)21 Form 4 lines · source: SEC Form 4
Everything they disclosed
49 entries, newest first — one per disclosure report, one per Form 4 line- ▼ sold on the open market 9,812 shares of ExelixisSEC Form 412 August 2026Common Stock · traded 10 August 2026 · filed 12 August 2026
- was granted 8,367 shares of ExelixisSEC Form 429 May 2026Common Stock · traded 27 May 2026 · filed 29 May 2026
- exercised options over 3,856 shares of ExelixisSEC Form 48 May 2026Common Stock · traded 7 May 2026 · filed 8 May 2026
- ▼ sold on the open market 7,712 shares of ExelixisSEC Form 48 May 2026Common Stock · traded 7 May 2026 · filed 8 May 2026
- exercised options over 3,856 shares of Exelixis (a derivative holding)SEC Form 48 May 2026Option (right to buy) · traded 7 May 2026 · filed 8 May 2026
- was granted 975 shares of Johnson & Johnson (a derivative holding)SEC Form 427 April 2026Deferred Share Units · traded 23 April 2026 · filed 27 April 2026
- was granted 12,434 shares of HuntsmanSEC Form 417 February 2026Common Stock · traded 12 February 2026 · filed 17 February 2026
- was granted 12,434 shares of HuntsmanSEC Form 417 February 2026Common Stock · traded 12 February 2026 · filed 17 February 2026
- exercised options over 5,784 shares of Exelixis (a derivative holding)SEC Form 413 November 2025Option (right to buy) · traded 11 November 2025 · filed 13 November 2025
- exercised options over 5,784 shares of ExelixisSEC Form 413 November 2025Common Stock · traded 11 November 2025 · filed 13 November 2025
- ▼ sold on the open market 5,784 shares of ExelixisSEC Form 413 November 2025Common Stock · traded 11 November 2025 · filed 13 November 2025
- ▼ sold on the open market 18,838 shares of ExelixisSEC Form 413 November 2025Common Stock · traded 11 November 2025 · filed 13 November 2025
- was granted 9,812 shares of ExelixisSEC Form 430 May 2025Common Stock · traded 29 May 2025 · filed 30 May 2025
- was granted 1,316 shares of Johnson & Johnson (a derivative holding)SEC Form 428 April 2025Deferred Share Units · traded 24 April 2025 · filed 28 April 2025
- exercised options over 8,354 shares of Exelixis (a derivative holding)SEC Form 419 February 2025Option (right to buy) · traded 14 February 2025 · filed 19 February 2025
- exercised options over 8,354 shares of ExelixisSEC Form 419 February 2025Common Stock · traded 14 February 2025 · filed 19 February 2025
- ▼ sold on the open market 8,354 shares of ExelixisSEC Form 419 February 2025Common Stock · traded 14 February 2025 · filed 19 February 2025
- ▼ sold on the open market 3,856 shares of ExelixisSEC Form 419 February 2025Common Stock · traded 14 February 2025 · filed 19 February 2025
- was granted 9,717 shares of HuntsmanSEC Form 418 February 2025Common Stock · traded 13 February 2025 · filed 18 February 2025
- ▼ sold on the open market 20,201 shares of HuntsmanSEC Form 48 November 2024Common Stock · traded 6 November 2024 · filed 8 November 2024
- was granted 18,838 shares of ExelixisSEC Form 44 June 2024Common Stock · traded 31 May 2024 · filed 4 June 2024
- was granted 1,386 shares of Johnson & Johnson (a derivative holding)SEC Form 429 April 2024Deferred Share Units · traded 25 April 2024 · filed 29 April 2024
- was granted 6,895 shares of HuntsmanSEC Form 420 February 2024Common Stock · traded 15 February 2024 · filed 20 February 2024
- was granted 30,848 shares of Exelixis (a derivative holding)SEC Form 49 January 2024Option (right to buy) · traded 5 January 2024 · filed 9 January 2024
- was granted 15,424 shares of ExelixisSEC Form 49 January 2024Common Stock · traded 5 January 2024 · filed 9 January 2024
- was granted 1,194 shares of Johnson & Johnson (a derivative holding)SEC Form 42 May 2023Deferred Share Units · traded 27 April 2023 · filed 2 May 2023
- was granted 4,700 shares of HuntsmanSEC Form 421 February 2023Common Stock · traded 16 February 2023 · filed 21 February 2023
- was granted 3,533 shares of HuntsmanSEC Form 422 February 2022Common Stock · traded 17 February 2022 · filed 22 February 2022
- was granted 1,175 shares of Johnson & Johnson (a derivative holding)SEC Form 417 February 2022Deferred Share Units · traded 15 February 2022 · filed 17 February 2022
- was granted 5,073 shares of HuntsmanSEC Form 419 February 2021Common Stock · traded 17 February 2021 · filed 19 February 2021
- was granted 1,123 shares of Johnson & Johnson (a derivative holding)SEC Form 411 February 2021Deferred Share Units · traded 9 February 2021 · filed 11 February 2021
- gave away 2,000 shares of HuntsmanSEC Form 429 January 2021Common Stock · traded 24 November 2020 · filed 29 January 2021
- ▼ sold on the open market 15,251 shares of HuntsmanSEC Form 427 November 2020Common Stock · traded 24 November 2020 · filed 27 November 2020
- was granted 6,732 shares of HuntsmanSEC Form 418 February 2020Common Stock · traded 13 February 2020 · filed 18 February 2020
- was granted 1,221 shares of Johnson & Johnson (a derivative holding)SEC Form 413 February 2020Deferred Share Units · traded 11 February 2020 · filed 13 February 2020
- was granted 1,402 shares of Johnson & Johnson (a derivative holding)SEC Form 413 February 2019Deferred Share Units · traded 12 February 2019 · filed 13 February 2019
- was granted 6,399 shares of HuntsmanSEC Form 48 February 2019Common Stock · traded 6 February 2019 · filed 8 February 2019
- was granted 1,428 shares of Johnson & Johnson (a derivative holding)SEC Form 415 February 2018Deferred Share Units · traded 13 February 2018 · filed 15 February 2018
- was granted 4,120 shares of HuntsmanSEC Form 49 February 2018Common Stock · traded 7 February 2018 · filed 9 February 2018
- ▼ sold on the open market 4,507 shares of HuntsmanSEC Form 413 November 2017Common Stock · traded 10 November 2017 · filed 13 November 2017
- was granted 1,512 shares of Johnson & Johnson (a derivative holding)SEC Form 415 February 2017Deferred Share Units · traded 14 February 2017 · filed 15 February 2017
- was granted 6,426 shares of Huntsman (a derivative holding)SEC Form 43 February 2017Stock Units · traded 1 February 2017 · filed 3 February 2017
- was granted 1,629 shares of Johnson & Johnson (a derivative holding)SEC Form 410 February 2016Deferred Share Units · traded 8 February 2016 · filed 10 February 2016
- was granted 15,237 shares of Huntsman (a derivative holding)SEC Form 44 February 2016Stock Units · traded 3 February 2016 · filed 4 February 2016
- was granted 5,929 shares of Huntsman (a derivative holding)SEC Form 46 February 2015Stock Units · traded 4 February 2015 · filed 6 February 2015
- was granted 6,362 shares of Huntsman (a derivative holding)SEC Form 47 February 2014Stock Units · traded 5 February 2014 · filed 7 February 2014
- was granted 7,563 shares of Huntsman (a derivative holding)SEC Form 48 February 2013Stock Units · traded 6 February 2013 · filed 8 February 2013
- was granted 10,067 shares of Huntsman (a derivative holding)SEC Form 43 February 2012Stock Units · traded 1 February 2012 · filed 3 February 2012
- was granted 4,507 shares of HuntsmanSEC Form 49 May 2011Common Stock · traded 5 May 2011 · filed 9 May 2011
Positions come from the unitedstates/congress-legislators roster, the Office of Government Ethics and the SEC’s Form 4 index. Every disclosed line names its own source and links the document the government published; we print what the filing says and never a price we did not read from it. Headlines and links come from the GDELT Global Knowledge Graph — the story stays with the publisher. The portrait, where we have one, is the public-domain Congressional Bioguide photograph.